Skip to main content

CORRECTION article

Front. Neurol., 17 May 2022
Sec. Neuro-Oncology and Neurosurgical Oncology
Volume 13 - 2022 | https://doi.org/10.3389/fneur.2022.914268

Corrigendum: The Visual Acuity Outcome and Relevant Factors Affecting Visual Improvement in Pediatric Sporadic Chiasmatic–Hypothalamic Glioma Patients Who Received Surgery

This article is a correction to:

  1. The Visual Acuity Outcome and Relevant Factors Affecting Visual Improvement in Pediatric Sporadic Chiasmatic–Hypothalamic Glioma Patients Who Received Surgery

    1. Read original article
\nChihyi Liao,Chihyi Liao1,2Heng Zhang,Heng Zhang1,2Zhiming Liu,Zhiming Liu1,2Zhe Han,Zhe Han1,2Chunde Li,Chunde Li1,2Jian Gong,Jian Gong1,2Wei Liu,Wei Liu1,2Zhenyu Ma,Zhenyu Ma1,2Yongji Tian, Yongji Tian1,2*
  • 1Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
  • 2Beijing Key Laboratory of Brain Tumor, China National Clinical Research Center for Neurological Diseases, Center of Brain Tumor, Beijing Institute for Brain Disorders, Beijing, China

A Corrigendum on
The Visual Acuity Outcome and Relevant Factors Affecting Visual Improvement in Pediatric Sporadic Chiasmatic–Hypothalamic Glioma Patients Who Received Surgery

by Liao, C., Zhan, H., Liu, Z., Han, Z., Li, C., Gong, J., Liu, W., Ma, Z., and Tian, Y. (2020). Front. Neurol. 11:766. doi: 10.3389/fneur.2020.00766

In the original article, there was an error. The AUC of IVA + tumor size predicting VA improvement was incorrectly stated. A correction has been made to Results, Paragraph 6:

In the ROC analysis, the AUC of IVA predicting VA improvement was 0.787 (95% CI: 0.674–0.900, p < 0.001), and the AUC of IVA + tumor size predicting VA improvement was 0.831 (95% CI: 0.729–0.933, p < 0.001). For medium to large tumors, the AUC of tumor volume predicting VA outcome was 0.748 (95% CI: 0.641–0.883, p =0.005). The cutoff point of IVA level was 4.5 (sensitivity = 73.91%, specificity = 75.93%, positive predictive value = 56.67%, negative predictive value = 87.23%, accuracy=75.32). The cutoff point of tumor volume was 43.50 cm3 (sensitivity = 95.65%, specificity = 31.48%, positive predictive value = 37.29%, negative predictive value =94.44%, accuracy =50.65%) (Table 4).

Additionally, in the original article there was an error in the vision levels reported. A correction has been made to Methods, Paragraph 2:

According to the range of vision loss reported by the International Council of Ophthalmology (12), we converted the categories of vision impairment to a seven-level scale: level 7 to level 1 represent normal vision (≥0.8), mild visual impairment (0.32–0.63), moderate visual impairment (0.125–0.25), severe visual impairment (0.05–0.1), profound visual impairment (0.02–0.04), near-blindness (<0.02), and light perception or blindness, respectively. The VA outcome of patients was categorized into “VA improvement” and “no VA improvement.” If the LVA level was higher than the IVA level, the outcome was defined as “VA improvement.” If not, the outcome was defined as “no VA improvement.” “Maintained” was used when the LVA level was equal to the IVA level, and “deteriorated” was used when the LVA level was lower than the IVA level. Tumor volume was calculated using the ellipsoid volume formula “A × B × C × π/6” (Figure 1) (13). Tumors were divided into small, medium, and large size groups by tertiles. Tumor volume ≤13.80 cm3 was categorized as a small-size tumor, 13.80 cm3 < tumor volume ≤34.60 cm3 was categorized as a medium-size tumor, and the tumor volume > 34.60 cm3 was categorized as a large-size tumor.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: chiasmatic–hypothalamic glioma, optic pathway glioma, visual acuity, prognostic factors, primary surgical treatment

Citation: Liao C, Zhang H, Liu Z, Han Z, Li C, Gong J, Liu W, Ma Z and Tian Y (2022) Corrigendum: The Visual Acuity Outcome and Relevant Factors Affecting Visual Improvement in Pediatric Sporadic Chiasmatic–Hypothalamic Glioma Patients Who Received Surgery. Front. Neurol. 13:914268. doi: 10.3389/fneur.2022.914268

Received: 06 April 2022; Accepted: 25 April 2022;
Published: 17 May 2022.

Edited and reviewed by: David D. Eisenstat, Royal Children's Hospital, Australia

Copyright © 2022 Liao, Zhang, Liu, Han, Li, Gong, Liu, Ma and Tian. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Yongji Tian, dHR5eXN3MXR5aiYjeDAwMDQwOzE2My5jb20=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.